'Disease indication type' presentation slideshows

Insulin Biosimilars Market Advancements to Watch Out For 2026

Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar.

67 views • 4 slides